Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications avec texte intégral
Open Access
53 %
Mots clés
DMPK
In vivo
CTG repeat contractions
Hypoxia
Muscle
DM1
Glial cells
Animals
Cell model
Fibrosis
CRISPR/Cas9
Centronuclear myopathy
Quantitative microdialysis
Neuron
Cell penetrating peptide
Oligodendrocytes
Myotonic dystrophy
Glucocorticoids
Mice
Cytoskeleton
Myotonic Dystrophy type 1
CTG repeat instability
Glutamate
Mouse model
Brain
Cardiac muscle
Trinucleotide Repeat Expansion
Antisense oligonucleotide
Dystrophie myotonique
Transcriptomics
KNOCKOUT MICE
Exercise
Myostatin
Dystrophin
CTG repeats
Mouse models
Aging
CMS
CRISPRi
Genotype phenotype correlation
Myotonic dystrophy mouse models
Myotonic Dystrophy Type 1
Dystrophie Myotonique
Central nervous system
RNA splicing
Muscular dystrophy
Intermediate filament
Transgenic mouse
Desmin
Dilated cardiomyopathy
Gene Therapy
Glucocorticoid-receptor
Brain dysfunction
Dynamin 2
AAV
Endurance training
Acetylcholinesterase knockout mouse
Myotonic Dystrophy
RNA biology
Thérapie génique
Gene therapy
ARN
MBNL
Autophagy
Acetylcholinesterase deficiency
Long read sequencing
Diaphragm
Male
Expression
Heart
Myelin
Astrocyte
Therapy
Cell culture model
Heart failure
PCR
Transgenic mouse model
BIOLOGIE MOLECULAIRE
GSK3
Antisense oligonucleotides
CONGENITAL MYATHENIC SYNDROME
Maximal force
PacBio
Motoneuron
Astrocytes
Oligodendrocyte
DMSXL mice
Acute coronary syndrome
Trinucleotide repeat expansion
Skeletal muscle
ACETYLCHOLINESTERASE
Myotonic dystrophy type 1
GABA
Duchenne muscular dystrophy
Gene editing
Exercice
Humans
Alternative splicing
Knockout
RNA interference